First evidence for the antitumor activity of nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic biliary tract cancer

被引：0
|
作者：
Hossein Taghizadeh
Matthias Unseld
Andreas Schmiderer
Angela Djanani
Klaus Wilthoner
Dieter Buchinger
Gerald W. Prager
机构：
[1] Medical University of Vienna,Clinical Division of Oncology, Department of Medicine I
[2] Comprehensive Cancer Center,Clinical Division of Gastroenterology, Hepatology and Metabolism, Department of Internal Medicine I
[3] Medical University Innsbruck,Clinical Division of Oncology, Department of Medicine I
[4] Salzkammergut Klinikum,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 86卷
关键词：
Biliary tract cancer; Chemotherapy; Nanoliposomal irinotecan; Progression-free survival; Overall survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：109 / 115
页数：6
相关论文
共 50 条
  • [41] Phase II trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer
    Cure, H
    Chevalier, V
    Pezet, D
    Bousquet, J
    Focan, C
    Levi, F
    Garufi, C
    Chipponi, J
    Chollet, P
    ANTICANCER RESEARCH, 2000, 20 (6C) : 4649 - 4653
  • [42] Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer
    Porschen, R
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1996, 34 (09): : 549 - 551
  • [43] A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX)
    Atkins, Katelyn Mae
    Gong, Jun
    Tighiouart, Mourad
    Klempner, Samuel J.
    Tuli, Richard
    Placencio-Hickok, Veronica
    Hendifar, Andrew Eugene
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [44] A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX).
    Hendifar, Andrew Eugene
    Kim, Sungjin
    Tighiouart, Mourad
    Hautamaki, Emily
    Kim, Haesoo
    Ng, Camille
    Liu, Jar-Yee
    Scher, Kevin S.
    Klempner, Samuel J.
    Placencio-Hickok, Veronica
    Gresham, Gillian
    Gong, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial
    Matteo Dalla Chiesa
    Gianluca Tomasello
    Sebastiano Buti
    Rodrigo Kraft Rovere
    Matteo Brighenti
    Silvia Lazzarelli
    Gianvito Donati
    Rodolfo Passalacqua
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 41 - 48
  • [46] Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer:: a Phase II study
    Francois, Eric
    Berdah, Jean-Francois
    Chamorey, Emmanuel
    Lesbats, Gerard
    Teissier, Eric
    Codoul, Jean-Francois
    Badetti, Jean-Luc
    Hebert, Christophe
    Mari, Veronique
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (06) : 931 - 936
  • [47] A phase II trial of second-line irinotecan and capecitabine after failure of first line infusional 5-fluorouracil and folinic acid in metastatic colorectal cancer (MCRC).
    Willer, AM
    Hofheinz, RD
    Wein, A
    Gnad-Vogt, U
    Saussele, S
    Hehlmann, R
    Hochhaus, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 307S - 307S
  • [48] Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin
    Takeshi Kawakami
    Akiko Todaka
    Kotoe Oshima
    Kunihiro Fushiki
    Satoshi Hamauchi
    Takahiro Tsushima
    Tomoya Yokota
    Yusuke Onozawa
    Hirofumi Yasui
    Kentaro Yamazaki
    BMC Cancer, 23
  • [49] Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial
    Dalla Chiesa, Matteo
    Tomasello, Gianluca
    Buti, Sebastiano
    Rovere, Rodrigo Kraft
    Brighenti, Matteo
    Lazzarelli, Silvia
    Donati, Gianvito
    Passalacqua, Rodolfo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (01) : 41 - 48
  • [50] Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study
    Eric François
    Jean-François Berdah
    Emmanuel Chamorey
    Gérard Lesbats
    Eric Teissier
    Jean-François Codoul
    Jean-Luc Badetti
    Christophe Hébert
    Véronique Mari
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 931 - 936
12345